Immuron Ltd Total Liabilities
Immuron Ltd total liabilities. Based on the latest financial reports, Immuron Ltd (IMC) has total liabilities worth AU$2.06 Million AUD (≈ $1.46 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of Immuron Ltd to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Immuron Ltd (2000–2025)
Total liabilities of Immuron Ltd from 2000 to 2025. This chart illustrates how Immuron Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore IMC long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Immuron Ltd Competitors by Total Liabilities
The table below lists competitors of Immuron Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Jenn Feng New Energy Co Ltd
TW:1538
|
Taiwan | NT$127.61 Million |
|
EA Holdings Bhd
KLSE:0154
|
Malaysia | RM17.96 Million |
|
Fiberweb (India) Limited
NSE:FIBERWEB
|
India | Rs-1.86 Billion |
|
Kyung In Elect
KO:009140
|
Korea | ₩9.82 Billion |
|
Synaptogenix Inc
NASDAQ:SNPX
|
USA | $1.83 Million |
|
Baillie Gifford Japan Trust
LSE:BGFD
|
UK | GBX114.78 Million |
|
NETUM GROUP OYJ
F:79J
|
Germany | €16.62 Million |
Liability Composition Analysis (2000–2025)
This chart breaks down Immuron Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see IMC total assets.
Liquidity & Leverage Metrics
Immuron Ltd Total Liabilities Ratios Explained
Immuron Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 8.04 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.16 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.14 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Immuron Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Immuron Ltd (2000–2025)
The table below shows the annual total liabilities of Immuron Ltd from 2000 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | AU$2.06 Million ≈ $1.46 Million |
-27.45% |
| 2024-06-30 | AU$2.84 Million ≈ $2.01 Million |
+19.79% |
| 2023-06-30 | AU$2.37 Million ≈ $1.68 Million |
+41.28% |
| 2022-06-30 | AU$1.68 Million ≈ $1.19 Million |
+44.94% |
| 2021-06-30 | AU$1.16 Million ≈ $819.39K |
+107.44% |
| 2020-06-30 | AU$558.25K ≈ $395.00K |
-53.88% |
| 2019-06-30 | AU$1.21 Million ≈ $856.51K |
+50.69% |
| 2018-06-30 | AU$803.34K ≈ $568.41K |
-53.06% |
| 2017-06-30 | AU$1.71 Million ≈ $1.21 Million |
-55.97% |
| 2016-06-30 | AU$3.89 Million ≈ $2.75 Million |
+221.82% |
| 2015-06-30 | AU$1.21 Million ≈ $854.60K |
+42.89% |
| 2014-06-30 | AU$845.30K ≈ $598.10K |
-64.51% |
| 2013-06-30 | AU$2.38 Million ≈ $1.69 Million |
+49.95% |
| 2012-06-30 | AU$1.59 Million ≈ $1.12 Million |
+71.18% |
| 2011-06-30 | AU$927.84K ≈ $656.50K |
+113.25% |
| 2010-06-30 | AU$435.10K ≈ $307.86K |
-35.82% |
| 2009-06-30 | AU$677.90K ≈ $479.66K |
-14.16% |
| 2008-06-30 | AU$789.69K ≈ $558.76K |
-39.80% |
| 2007-06-30 | AU$1.31 Million ≈ $928.12K |
-5.39% |
| 2006-06-30 | AU$1.39 Million ≈ $981.03K |
+27.02% |
| 2005-06-30 | AU$1.09 Million ≈ $772.34K |
+31.25% |
| 2004-06-30 | AU$831.69K ≈ $588.47K |
-8.71% |
| 2003-06-30 | AU$911.00K ≈ $644.59K |
+258.88% |
| 2002-06-30 | AU$253.84K ≈ $179.61K |
-28.75% |
| 2001-06-30 | AU$356.28K ≈ $252.09K |
+484.07% |
| 2000-06-30 | AU$61.00K ≈ $43.16K |
-- |
About Immuron Ltd
Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United States, and Canada. It operates through two segments, Research and Development; and Hyper-immune Products. The company offers Travelan, an over-the-counter medicine to reduce the risk of travelers' diarrhea and risk of minor gastrointestinal d… Read more